新型黄疸计用于低资源地区新生儿高胆红素血症筛查
本研究在波士顿和孟加拉国两家医院纳入790名新生儿,验证一种基于数字色彩处理的新型黄疸计Bili-ruler,并与经皮胆红素和血清总胆红素比较。Bili-ruler鼻部评分与两者相关性良好,鉴别不同胆红素阈值具有较高敏感度和特异度,可作为低资源地区筛查工具。
要点
- Bili-ruler鼻部评分与TcB和TSB相关系数分别为0.76和0.78。
- 评分≥3.5鉴别TcB≥13 mg/dL的敏感度90.1%、特异度85.9%。
- 评分≥3.5鉴别TSB≥11 mg/dL的敏感度84.5%、特异度83.2%。
核心结论
- Bili-ruler是一种低成本、无创且诊断准确度较高的新生儿黄疸筛查工具。
- 该设备可用于改善社区或 peripheral 卫生中心向具备胆红素检测和/或光疗能力的高级别机构转诊。
研究设计与样本
- Bili-ruler验证研究在布莱根妇女医院(波士顿)和Sylhet Osmani医学院医院(孟加拉国Sylhet)开展,共纳入790名新生儿。
- 独立进行Bili-ruler测量,并与参考标准经皮胆红素(TcB)和血清总胆红素(TSB)浓度比较。
主要发现
- Bili-ruler鼻部评分与TcB和TSB水平相关,r分别为0.76和0.78。
- Bili-ruler可区分由TcB定义的不同临床高胆红素血症阈值,评分≥3.5时对TcB≥13 mg/dL的敏感度为90.1%(95%CI:84.8%-95.4%),特异度为85.9%(95%CI:83.2%-88.6%)。
- 与TSB比较,评分≥3.5时对TSB≥11 mg/dL的敏感度为84.5%(95%CI:79.1%-90.3%),特异度为83.2%(95%CI:76.1%-90.3%)。
- 识别TcB≥11、≥13和≥15 mg/dL的ROC曲线下面积分别为0.92、0.93和0.94;识别TSB≥11、≥13和≥15 mg/dL的ROC曲线下面积分别为0.90、0.87和0.86。
- 评分者间信度高,独立读者评分中97%落在彼此1分以内(N=88)。
关键数值与推荐
- Bili-ruler评分≥3.5鉴别TcB≥13 mg/dL:敏感度90.1%(95%CI:84.8%-95.4%),特异度85.9%(95%CI:83.2%-88.6%)。
- Bili-ruler评分≥3.5鉴别TSB≥11 mg/dL:敏感度84.5%(95%CI:79.1%-90.3%),特异度83.2%(95%CI:76.1%-90.3%)。
- 识别TcB≥11、≥13和≥15 mg/dL的ROC曲线下面积分别为0.92、0.93和0.94。
- 识别TSB≥11、≥13和≥15 mg/dL的ROC曲线下面积分别为0.90、0.87和0.86。
临床怎么用
- 在低资源社区或 peripheral 卫生中心,可使用Bili-ruler进行无创黄疸筛查。
- 评分较高者应转诊至具备胆红素检测和/或光疗能力的高级别机构。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe neonatal hyperbilirubinemia (>20 mg/dL) affects ∼1 million infants annually. Improved jaundice screening in low-income countries is needed to prevent bilirubin encephalopathy and mortality. METHODS: The Bili-ruler is an icterometer for the assessment of neonatal jaundice that was designed by using advanced digital color processing. A total of 790 newborns were enrolled in a validation study at Brigham and Women's Hospital (Boston) and Sylhet Osmani Medical College Hospital (Sylhet, Bangladesh). Independent Bili-ruler measurements were made and compared with reference standard transcutaneous bilirubin (TcB) and total serum bilirubin (TSB) concentrations. RESULTS: Bili-ruler scores on the nose were correlated with TcB and TSB levels (r = 0.76 and 0.78, respectively). The Bili-ruler distinguished different clinical thresholds of hyperbilirubinemia, defined by TcB, with high sensitivity and specificity (score ≥3.5: 90.1% [95% confidence interval (CI): 84.8%-95.4%] and 85.9% [95% CI: 83.2%-88.6%], respectively, for TcB ≥13 mg/dL). The Bili-ruler also performed reasonably well compared to TSB (score ≥3.5: sensitivity 84.5% [95% CI: 79.1%-90.3%] and specificity 83.2% [95% CI: 76.1%-90.3%] for TSB ≥11 mg/dL). Areas under the receiver operating characteristic curve for identifying TcB ≥11, ≥13, and ≥15 were 0.92, 0.93, and 0.94, respectively, and 0.90, 0.87, and 0.86 for identifying TSB ≥11, ≥13, and ≥15. Interrater reliability was high; 97% of scores by independent readers fell within 1 score of one another (N = 88). CONCLUSIONS: The Bili-ruler is a low-cost, noninvasive tool with high diagnostic accuracy for neonatal jaundice screening. This device may be used to improve referrals from community or peripheral health centers to higher-level facilities with capacity for bilirubin testing and/or phototherapy.
引用
- Lee AC, Folger LV, Rahman M, et al. A Novel Icterometer for Hyperbilirubinemia Screening in Low-Resource Settings. Pediatrics. 2019. PMID: 30952779. doi:10.1542/peds.2018-2039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。